Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1419 | Ribociclib | 10.0 | 0.6250 | 0.01559 |
| HCC1419 | Ribociclib | 10.0 | 0.5251 | 0.01170 |
| HCC1419 | Ribociclib | 10.0 | 0.4859 | 0.02907 |
| HCC1419 | LY3023414 | 0.001 | 0.96465 | |
| HCC1419 | LY3023414 | 0.001 | 0.1901 | 0.01972 |
| HCC1419 | LY3023414 | 0.001 | 0.2630 | 0.00510 |
| HCC1419 | LY3023414 | 0.00316227766017 | 0.0291 | 0.02404 |
| HCC1419 | LY3023414 | 0.00316227766017 | 0.1970 | 0.02243 |
| HCC1419 | LY3023414 | 0.00316227766017 | 0.2001 | 0.00911 |
| HCC1419 | LY3023414 | 0.01 | 0.1202 | 0.00904 |
| HCC1419 | LY3023414 | 0.01 | 0.1575 | 0.05302 |
| HCC1419 | LY3023414 | 0.01 | 0.1297 | 0.03272 |
| HCC1419 | LY3023414 | 0.0316227766017 | -0.0507 | 0.04103 |
| HCC1419 | LY3023414 | 0.0316227766017 | 0.1080 | 0.01943 |
| HCC1419 | LY3023414 | 0.0316227766017 | 0.0668 | 0.02212 |
| HCC1419 | LY3023414 | 0.1 | -0.0710 | 0.04723 |
| HCC1419 | LY3023414 | 0.1 | 0.2013 | 0.03192 |
| HCC1419 | LY3023414 | 0.1 | 0.0939 | 0.03141 |
| HCC1419 | LY3023414 | 0.316227766017 | -0.0272 | 0.03479 |
| HCC1419 | LY3023414 | 0.316227766017 | 0.0415 | 0.01640 |
| HCC1419 | LY3023414 | 0.316227766017 | -0.0179 | 0.05020 |
| HCC1419 | LY3023414 | 1.0 | -0.0085 | 0.03237 |
| HCC1419 | LY3023414 | 1.0 | 0.0238 | 0.03419 |
| HCC1419 | LY3023414 | 1.0 | 0.0021 | 0.02839 |
| HCC1419 | LY3023414 | 3.16227766017 | -0.1840 | 0.02892 |